Article Information
History
- November 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Meghan Delaney1,2,*,
- Joelle Simpson3,4,
- Bobbe Thomas3,
- Christal Ralph1,
- Michael Evangalista1,
- Mahdi Moshgriz1,
- Joyce Granados1,
- Mark McGuire1,
- Roberta DeBiasi5,6 and
- Joseph Campos1,5
- 1Division of Pathology and Laboratory Medicine, Children’s National Hospital
- 2Departments of Pathology and Pediatrics, The George Washington University School of Medicine and Health Sciences
- 3Division of Emergency Medicine, Children’s National Hospital
- 4Department of Emergency Medicine & Pediatrics, The George Washington University School of Medicine and Health Sciences
- 5Division of Infectious Diseases, Children’s National Hospital
- 6Departments of Pediatrics, Pathology, and Microbiology/Immunology/Tropical Medicine, The George Washington University School of Medicine and Health Sciences
- ↵*Corresponding Author:
Meghan Delaney, Division of Pathology and Laboratory Medicine, Children’s National Hospital, 111 Michigan Ave NW, Washington, DC, 20010, mdelaney2{at}childrensnational.org, +1(202) 476 5974
Posted November 13, 2020.
The Use of Saliva as a Diagnostic Specimen for SARS CoV-2 Molecular Diagnostic Testing for Pediatric Patients
